Back

Smaller Infarct Size with Ticagrelor vs. Clopidogrel in STEMI Patients: Insights from Cardiac MRI

2025-01-09 cardiovascular medicine Title + abstract only
View on medRxiv
Show abstract

BACKGROUNDTicagrelor has many protective cardiovascular properties in addition to its potent antiplatelet action. This study aims to compare the effects of ticagrelor versus clopidogrel on infarcted mass, quantified by cardiac magnetic resonance imaging (cMRI), in patients with ST-segment elevation acute myocardial infarction (STEMI). METHODS AND RESULTSAdult patients of both sexes with STEMI under pharmaco-invasive strategy were included (n=225). Patients were thrombolized within six hours of ...

Predicted journal destinations